Pharmaceutical Executive February 9, 2024
Mike Hollan

According to the study conducted by Technavio, North America will contribute to 37% of the expected growth.

The generic drug market is expected to show significant growth in the coming years.

At least, that’s according to a new study conducted by Technavio, a leading global technology research and advisory company.1 In a press release, the research company detailed the estimated growth, stating that it believes the market will grow by $176.25 billion by 2027. It also states that North America will contribute about 37% of this growth.

In the press release, a senior analyst at Technavio said, “The rising drug patent expirations are notably driving the generic drug market growth. Patent...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma, Pharma / Biotech, Survey / Study, Trends
Drugmakers counter HHS' first offers in Medicare price talks
Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question
Walgreens CEO: Shields Specialty Pharmacy Key To Growth And Won’t Be Sold
ARPA-H behind on duplicative research efforts, GAO says
Retail pharmacies to begin selling OTC birth control within weeks

Share This Article